Imperial Innovations led the investment round of the oncology company.

The online fashion retailer, backed by Anders Holch Povlsen, Holtzbrinck and Tengelmann, floated near the top of its range and could raise up to $765m before the IPO closes.

Adaptimmune, which focuses on the use of T-cell therapy to treat cancer and infectious diseases, has completed a huge series A round to expand its clinical trials.

Accuris Networks, a provider of a cellular and wifi connectivity platform, has raised $15m in funding and appointed a new chief executive, Jeff Brown.

Star Dundee has been named Business of the Year at the Scottish Business Honours.

Amsterdam spin-out Photanol is partnering with industry to develop new chemical building blocks.

3Dynamic Systems launches two 3D bioprinters.

Cancer diagnostics company Inivata, which works with technology spun-out from Cancer Research UK, has received $6m in its first external venture round.

The bank's corporate venturing unit contributed to an expansion of Taulia's series D round increasing its overall funding to $70m.

Bradford spin-out Tangentix has secured further investment from Parkwalk Advisors.